Last reviewed · How we verify
blood specimen
Blood specimen is a diagnostic sample collection, not a drug with a pharmacological mechanism.
At a glance
| Generic name | blood specimen |
|---|---|
| Sponsor | Centre Hospitalier Universitaire de Saint Etienne |
| Modality | Biologic |
| Phase | FDA-approved |
Mechanism of action
Blood specimen refers to a biological sample collected for laboratory analysis and diagnostic testing. It is not a pharmaceutical agent and does not have a therapeutic mechanism of action. This appears to be a mislabeling or data entry error in a pharmaceutical database.
Approved indications
Common side effects
Key clinical trials
- Wild Blueberries for Gut, Brain, and Heart Health in Adults With High Blood Pressure (NA)
- Collection of Blood From Patients With Prostate Cancer
- The Effect of Continuous Positive Airway Therapy on the Blood Pressure in Sleepy vs Non-sleepy Patients With Obstructive Sleep Apnea
- Screening and Multiple Intervention on Lung Epidemics (PHASE2)
- Clinical Outcome and Cost-effectiveness of Reduced Noradrenaline by Using a Lower Blood Pressure Target in Patients With Cardiogenic Shock From Acute Myocardial Infarction (PHASE4)
- Efficacy of Nigella Sativa (Nisatol®) in Women With Borderline Blood Pressure Values or a Non-Dipper Blood Pressure Phenotype (NA)
- Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer (PHASE2)
- Study of New Magnetic Resonance Imaging Methods of the Brain
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- blood specimen CI brief — competitive landscape report
- blood specimen updates RSS · CI watch RSS
- Centre Hospitalier Universitaire de Saint Etienne portfolio CI